1996 Fiscal Year Final Research Report Summary
STUDY ON MECHANISM OF TUMOR ANGIOGENESIS IN UROTHELIAL CANCERS AND SCREENING OF ANGIOGENIC INHIBITORS
| Project/Area Number |
07671739
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Urology
|
|---|
| Research Institution | OITA MEDICAL UNIVERSITY |
|---|
Principal Investigator |
NAKAGAWA Masayuki OITA MEDICAL UNIVERSITY,UROLOGY,ASSOCIATE PROFESSOR, 医学部泌尿器科, 助教授 (90164144)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TASAKI Yoshihisa OITA MEDICAL UNIVERSITY,UROLOGY,ASSISTANT PROFESSOR, 医学部泌尿器科, 助手 (80244177)
|
|---|
| Project Period (FY) |
1995 – 1996
|
| Keywords | angiogenesis / bladder cancer / renal cancer / tubulogenesis |
|---|
| Research Abstract |
Tumor angiogenesis is essential for tumor growth and metastasis. Solid tumors depend on angiogenesis to grow larger than a few millimeters in diameter. To investigate the role of several angiogenic factors, such as b-FGF,VEGF,PDGF-A and TGF-alpha in angiogenesis in urothelial cancers, we examined the expression and localization of these angiogenic factors in patients with bladder cancers and renal cell carcinomas. Furthermore, tubulogenesis by VEGF and b-FGF of microvascular endothelial cells co-cultured with renal cancer cells was also examined by a three dimensional co-culture assay system. RT-PCR analysis detected mRNAs of b-FGF,VEGF,PDGF-A and TGF-alpha in 96%, 77%, 69% and 50% in renal cancers and 77%, 62%, 62% and 0% in bladder cancers, respectively. Immunohistochemical analysis revealed that b-FGF and VEGF were primarily localized in the nucleus and cytosol, respectively. Exogenous addition of b-FGF and VEGF increased tube formation of microvascular endothelial cells in a dose dependent manner in the three dimensional co-culture assay system. However, specific antibodies against b-FGF (10mug/ml) and VEGF (10mug/ml) completely inhibited the tube formation in the system, suggesting that neutral antibodies against angiogenic factors, including b-FGF and VEGF may suppress tumor growth by the inhibition of tumor angiogenesis. Recently, we observed that the expression of TGF-alpha increased as a function of tumor size in nude mice bearing bladder tumors, although the expression of TGF-alpha in the original bladder tumor was weak. Furthermore, we observed that bladder tumors which highly express PD-ECGF showed high tumor microvascular density determined by von-Willebrand factor. Thses results suggest that several angiogenic factors were involved in the multi-steps of tumor angiogenesis of urothelial cancers. Specific antibodies against these angiogenic factors may be clinically applicable to the cancer treatment.
|
-
-
-
-
-
[Publications] Emoto, A., Nakagawa, M., Wakabayashi, Y., Hanada, T., Naito, S.and Nomura, Y.: "Induction of tubulogenesis of microvascular endothelial cells by basic fibroblast growth factor from human SN12C renal cancer cells." J.Urol.157. 699-703 (1997)
Description
「研究成果報告書概要(欧文)」より
-
-
[Publications] Nakagawa, M., Emoto, A., Nasu, N., Hanada, T., Kuwano, N., Cole, S.P.C.and Nomura, Y.: "Clinical significance of multi-drug resistance associated protein and Pglycoprotein in patients with bladder cancer." J.Urol.157. 1260-1265 (1997)
Description
「研究成果報告書概要(欧文)」より
